Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Alpha Wealth Funds - The Insiders Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
YTD+8.5%
Positioning StanceCONSTRUCTIVE
Market CapAll Cap
Digest Analysis
Quick Take
"The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the period 95% invested in a supportive 'goldilocks' environment."
Executive Summary
The Insiders Fund, LP ended June 2025 up ~5.27%, with YTD returns reaching ~8-9%. Outperforming the S&P 500's downside volatility, the fund has rotated significantly into tech (Alphabet, AMD, Applied Materials) and reduced healthcare sector exposure due to anticipated policy headwinds from DOGE and HHS. Major positions in Energy Transfer and AppFolio highlight the fund's strategy of navigating tariff risks. The fund remains 95% invested, pointing to lower interest rates and priced-in geopolitical risks as supportive factors for a continuation of the market's bullish trend.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
80%
CautiousHigh
High Conviction (80%)
High-conviction positioning: The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Growth Outlook
80%
BearishBullish
Bullish (80%)
Market outlook remains high conviction: The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Risk Appetite
85%
DefensiveAggressive
Aggressive (85%)
Risk appetite posture is high conviction: The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Capital Deployment
95%
De-riskingDeploying
Deploying (95%)
Manager actively deployed capital into high-conviction opportunities. The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Forward Guidance
50%
CautiousExpansionary
Neutral (50%)
Forward guidance signal: The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Language Signal
70%
BearishBullish
Bullish (70%)
Tone analysis indicates above average conviction language: The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Perceived Risk
40%
Low RiskElevated
Moderate Risk (40%)
Perceived risk level is evaluated as moderate conviction. The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Opportunity Density
70%
ScarceAbundant
Abundant (70%)
Opportunity density index indicates above average conviction actionable entry points. The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Time Horizon
70%
Short-TermLong-Term
Decade+ (70%)
Investment time horizon reflects a above average conviction orientation. The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...